Terapevticheskii arkhiv 1995-01-01

[Beclomethasone dipropionate, budesonide and flunisolide in the treatment of bronchial asthma (a review of the literature and the authors' own research)].

I M Kakhnovskiĭ, A S Solomatin

文献索引：Ter. Arkh. 67(3) , 34-8, (1995)

全文：HTML全文

摘要

Inhalation corticosteroids (beclometasone dipropionate, budesonide, flunisolide) proved effective against bronchial asthma (BA) and safe as they induce no severe systemic side effects. Of these three drugs side effects arise most frequently in administration of beclometasone dipropionate, least frequently of flunisolide. These inhalation corticosteroids are indicated both in non-steroid-dependent and steroid-dependent BA to reduce the dose of oral steroids or, if possible, for their complete discontinuation. Flunisolide is the most potent and effective of all inhalation corticosteroids used in current practice.

相关化合物

  • 氟尼缩松
  • 丙酸倍氯米松

相关文献：

Detection and characterization of triamcinolone acetonide metabolites in human urine by liquid chromatography/tandem mass spectrometry after intramuscular administration.

2014-08-30

[Rapid Commun. Mass Spectrom. 28(16) , 1829-39, (2015)]

Intranasal flunisolide treatment in patients with non-allergic rhinitis.

2011-01-01

[Int. J. Immunopathol. Pharmacol. 24(2) , 401-9, (2011)]

Evaluation of efficacy and safety of flunisolide hydrofluoroalkane for the treatment of asthma.

2003-03-01

[Clin. Ther. 25(3) , 776-98, (2003)]

High-dose inhaled flunisolide versus budesonide in the treatment of acute asthma exacerbations in preschool-age children.

2009-01-01

[Int. J. Immunopathol. Pharmacol. 22(2) , 363-70, (2009)]

Late (≥ 7 days) inhalation corticosteroids to reduce bronchopulmonary dysplasia in preterm infants.

2012-01-01

[Cochrane Database Syst. Rev. 4 , CD002311, (2012)]

更多文献...